Samsung Biologics Signs 88.4 Billion KRW Contract Manufacturing Deal with European Pharmaceutical Company
Samsung Biologics announced on the 26th that it has signed a contract manufacturing agreement worth 88,427,220,000 KRW with a European pharmaceutical company.
This amount is equivalent to 1.94% of the previous year's sales.
Hot Picks Today
"Samsung Electronics Employee with 100 Million Won Salary Receiving 600 Million Won Bonus... Estimated Tax Revealed"
- "Only Two Per Person" Garbage Bag Crisis Was Just Yesterday... Japan Also Faces Shortage Anxiety
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- Despite ‘Tank Day’ Controversy, Gwangju Schools Purchased Starbucks Gift Certificates
- "Wore It Once, Then This? White Spots All Over 4.15 Million Won Prada Jacket... 'Full Refund Ordered'"
Samsung Biologics stated, "The identity of the contracting party will be disclosed on December 31, 2031, due to business confidentiality," and added, "The contract end date may be subject to change based on mutual agreement between the two companies."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
